Bogle Investment Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Bogle Investment Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-4,452	Closed	-$455K	–	366
2020 Q2	$455K	Sell	4,452 -29,726	-87%	-$3.18M	0.08%	213
2020 Q1	$3.69M	Sell	34,178 -2,027	-6%	-$233K	0.39%	89
2019 Q4	$4.21M	Buy	+36,205	New	+$4.19M	0.39%	90
2017 Q4	–	Sell	-12,989	Closed	-$1.2M	–	404
2017 Q3	$1.2M	Buy	+12,989	New	+$1.25M	0.08%	213
2016 Q1	–	Sell	-88,870	Closed	-$12.7M	–	522
2015 Q4	$12.7M	Buy	+88,870	New	+$10.3M	0.91%	11
2015 Q3	–	Sell	-108,406	Closed	-$12.5M	–	490
2015 Q2	$12.5M	Buy	108,406 +76,700	+242%	+$8.06M	0.93%	14
2015 Q1	$3.03M	Sell	31,706 -4,314	-12%	-$323K	0.21%	134
2014 Q4	$2.42M	Buy	36,020 +8,461	+31%	+$524K	0.16%	177
2014 Q3	$1.49M	Buy	+27,559	New	+$1.36M	0.1%	214

Other funds holding CBPO

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capstone Investment Advisors New York $57.4B AUM 26.91% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Bogle Investment Management's CBPO Position: Q3 2020 in Review

Bogle Investment Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2020, closing a stake of 4,452 shares — an estimated $455K sold.

Bogle Investment Management first reported a position in CBPO in Q3 2014 and held it in 9 quarters. The position peaked at $12.7M in Q4 2015. 87 funds tracked by Wall St. Rank hold CBPO as of Q3 2020.

Bogle Investment Management reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2020 after selling out during the quarter.
Bogle Investment Management sold 4,452 China Biologic Products Holdings, Inc. shares in Q3 2020, an estimated $455K.
Bogle Investment Management first reported a position in China Biologic Products Holdings, Inc. in Q3 2014 and held it in 9 quarters.
Bogle Investment Management's China Biologic Products Holdings, Inc. position peaked at $12.7M in Q4 2015.
87 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2020.

Based on Bogle Investment Management's 13F filing for Q3 2020, filed 12 Nov 2020.